GUILDFORD, England--(BUSINESS WIRE)--A rigorous evaluation by researchers at University Medical Centre Hamburg-Eppendorf (UKE) published in the International Journal of Cancer today of ANGLE’s ParsortixTM cell separation system demonstrated significant advantages of its size and deformability based enrichment technology, versus marker-based and filtration enrichment systems.
